Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug

Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug#Pfizer #signs #billion #licensing #deal #China039s #3SBio #cancer #drug